Detalhe da pesquisa
1.
Phase II Study of Pembrolizumab As First-Line, Single-Drug Therapy for Patients With Unresectable Cutaneous Squamous Cell Carcinomas.
J Clin Oncol
; 38(26): 3051-3061, 2020 09 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32730186
2.
Topical Mineralocorticoid Receptor Blockade Limits Glucocorticoid-Induced Epidermal Atrophy in Human Skin.
J Invest Dermatol
; 135(7): 1781-1789, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25668238
3.
Phenotypic and functional characteristics of blood natural killer cells from melanoma patients at different clinical stages.
PLoS One
; 8(10): e76928, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-24204708
4.
Phase II study of cetuximab as first-line single-drug therapy in patients with unresectable squamous cell carcinoma of the skin.
J Clin Oncol
; 29(25): 3419-26, 2011 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21810686